Karyopharm Therapeutics (KPTI) Cash & Current Investments (2012 - 2026)
Karyopharm Therapeutics (KPTI) posted Cash & Current Investments of $65.11 million for Q2 2026, up 25.9% from $51.7 million a year earlier.
Karyopharm Therapeutics (KPTI) Cash & Current Investments (2012 - 2026) Analysis & Trends
At the end of FY2025, Karyopharm Therapeutics' Cash & Current Investments came in at $63.74 million, down 41.4% from FY2024.
- Annual Cash & Current Investments has declined for three consecutive years, with a five-year compound annual growth rate of -23.9% (FY2020 to FY2025).
- In prior years, Karyopharm Therapeutics' Cash & Current Investments was $108.71 million in FY2024 (-43.2%), $191.44 million in FY2023 (-31.1%), $277.97 million in FY2022 (+21.6%) and $228.62 million in FY2021 (-8.3%).
- The Q2 2026 figure stands as the highest quarterly Cash & Current Investments since Q1 2025.
- On a year-over-year basis, Cash & Current Investments increased in 1 of the last seven quarters, with an average decline of 39.9%.
- The strongest year-over-year quarter for Cash & Current Investments in the past five years was Q3 2023, with growth of 40.4%; the weakest was Q2 2025, with a decline of 66.0%.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Karyopharm Therapeutics | 15.05 Mn | -211.38 Mn | 32.35 Mn | 65.11 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 65.11 Mn |
| Dec 31, 2025 | 63.74 Mn |
| Sep 30, 2025 | 45.88 Mn |
| Jun 30, 2025 | 51.70 Mn |
| Mar 31, 2025 | 69.94 Mn |
| Dec 31, 2024 | 108.71 Mn |
| Sep 30, 2024 | 133.53 Mn |
| Jun 30, 2024 | 152.12 Mn |
| Mar 31, 2024 | 148.58 Mn |
| Dec 31, 2023 | 191.44 Mn |
| Sep 30, 2023 | 208.32 Mn |
| Jun 30, 2023 | 236.77 Mn |
| Mar 31, 2023 | 260.38 Mn |
| Dec 31, 2022 | 277.97 Mn |
| Sep 30, 2022 | 148.38 Mn |
| Jun 30, 2022 | 170.85 Mn |
| Mar 31, 2022 | 205.31 Mn |
| Dec 31, 2021 | 228.62 Mn |
| Sep 30, 2021 | 204.21 Mn |
| Jun 30, 2021 | 235.89 Mn |
Karyopharm Therapeutics Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=KPTI&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "KPTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=KPTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();